What 9 Analyst Ratings Have To Say About Merit Medical Systems
Portfolio Pulse from Benzinga Insights
Nine analysts have provided varied opinions on Merit Medical Systems (NASDAQ:MMSI) over the past quarter, with ratings ranging from bullish to somewhat bullish. The average 12-month price target has increased by 2.34% to $99.78. Key analysts have maintained or adjusted their ratings and price targets, reflecting their perceptions of the company's market standing.
July 16, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have provided mixed ratings for Merit Medical Systems, with a recent increase in the average 12-month price target to $99.78. Key analysts have maintained or adjusted their ratings, reflecting their perceptions of the company's market standing.
The increase in the average 12-month price target and the maintenance or adjustment of ratings by key analysts indicate a positive sentiment towards Merit Medical Systems. This is likely to have a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100